Abstract
Neratinib (Nerlynx (TM)) is an oral, irreversible inhibitor of the human epidermal growth factor receptors HER1 (EGFR), HER2 and HER4. The drug origin......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
